[HTML][HTML] Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy

…, A Miyamoto, Y Inoue, S Akagawa, S Hashimoto… - Scientific Reports, 2023 - nature.com
While high-level evidence is lacking, numerous retrospective studies have depicted the
value of supplemental oxygen in idiopathic pulmonary fibrosis (IPF) and other interstitial lung …

Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®

…, Y Tanino, T Nikaido, Y Takaku, S Hashimoto… - Allergology …, 2021 - jstage.jst.go.jp
Background: Bird antigens are some of the most relevant antigens in hypersensitivity
pneumonitis (HP). Possible sources of bird antigens are bird breeding, feather products and …

[HTML][HTML] Prediction of forced vital capacity with dynamic chest radiography in interstitial lung disease

M Ueyama, S Hashimoto, A Takeda… - European Journal of …, 2021 - Elsevier
Purpose The pulmonary function test (PFT) has played an essential role in diagnosing and
managing interstitial lung disease (ILD) but has its contraindications and difficult conditions to …

Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan

Y Taguchi, M Ebina, S Hashimoto, T Ogura… - Respiratory …, 2015 - Elsevier
Background A phase III clinical trial of pirfenidone in patients with idiopathic pulmonary
fibrosis (IPF) in Japan has revealed that pirfenidone attenuated the decline in vital capacity (VC) …

Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in …

…, Y Waseda, Y Tanino, K Yatera, S Hashimoto… - Respiratory …, 2021 - Elsevier
… and Shionogi & Co., Ltd.; Shinyu Izumi, Susumu Sakamoto, Kizuku Watanabe, Yasuo Shimizu,
Hiromichi Hara, Yuko Waseda, Yoshinori Tanino, Seishu Hashimoto, and Naohiko Inase …

[HTML][HTML] A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib

…, K Yatera, Y Inoue, Y Miyazaki, S Hashimoto… - Scientific Reports, 2023 - nature.com
This study investigated the utility of periostin, a matricellular protein, as a prognostic biomarker
in patients with idiopathic pulmonary fibrosis (IPF) who received nintedanib. Monomeric …

[HTML][HTML] A case report of pulmonary Botrytis sp. infection in an apparently healthy individual

S Hashimoto, E Tanaka, M Ueyama, S Terada… - BMC infectious …, 2019 - Springer
Background Botrytis species are well known fungal pathogens of various plants but have
not been reported as human pathogens, except as allergenic precipitants of asthma and …

Nontuberculous mycobacteria in diffuse panbronchiolitis

…, Y Nakatsuka, Y Kaji, T Yasuda, S Hashimoto… - …, 2015 - Wiley Online Library
Background and objective Nontuberculous mycobacterial ( NTM ) lung disease secondary
to cystic fibrosis ( CF ) has been reported, but there is limited data about NTM prevalence in …

Pulmonary thrombosis with transient antiphospholipid syndrome after mononucleosis-like illness

…, M Sakuramoto, M Minakuchi, S Hashimoto… - Internal …, 2009 - jstage.jst.go.jp
Antiphospholipid antibodies (aPL) have been reported to occur in numerous viral infections.
We report a 24-year-old Japanese woman, who developed multiple venous thrombosis …

Chronic kidney disease predicts survival in patients with idiopathic pulmonary fibrosis

…, T Kubo, K Aihara, A Sokai, Y Nakatsuka, S Hashimoto… - Respiration, 2017 - karger.com
Background: The prevalence of chronic kidney disease (CKD) increases with age as with
idiopathic pulmonary fibrosis (IPF). Objectives: We assessed the prevalence of CKD (stages 3-…